Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$35.47

-0.03 (-0.08%)

09:43
12/30/17
12/30
09:43
12/30/17
09:43

'Good time' to buy GlaxoSmithKline stock, Barron's says

GalxoSmithKline's earnings estimates have been sliding and shares have tumbled since the summer, but now looks like a good time to buy the stock, Jack Hough writes in this week's edition of Barron's. While GlaxoSmithKline will suffer an earnings hit in 2018 from new generic competition, it should get back on track quickly, he contends. Reference Link

  • 25

    Mar

GSK GlaxoSmithKline
$35.47

-0.03 (-0.08%)

11/24/17
DBAB
11/24/17
NO CHANGE
Target $59
DBAB
Hold
Deutsche cuts Merck target to $59 on competition from AbbVie, GSK
Deutsche Bank analyst Gregg Gilbert lowered his price target for Merck (MRK) to $59 from $62 citing expectations for more competitive pressure on Zepatier and Zostavax. The stock closed Wednesday up 10c to $54.37. Demand trends for Merck's hepatitis C virus drug Zepatier have continued to decline as AbbVie's (ABBV) Mavyret has gained traction, Gilbert told investors in a research note. The analyst also assumes "significant pressure" on Merck's shingles vaccine Zostavax from the near-term competitive launch of GlaxoSmithKline's (GSK) Shingrix. Gilbert views Merck's risk/reward as fairly balanced and he keeps a Neutral rating on the shares.
11/27/17
UBSW
11/27/17
UPGRADE
UBSW
Buy
GlaxoSmithKline upgraded to Buy from Neutral at UBS
UBS analyst Michael Leuchten upgraded GlaxoSmithKline to Buy with an unchanged price target of 1,550p. Concerns of continuing earnings decline and the dividend sustainability are now overdone, Leuchten tells investors in a research note. The analyst believes the dividend looks secure and views the 6% forecast yield as "handsome."
11/27/17
11/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lowe's (LOW) upgraded to Outperform from Market Perform at Raymond James with analyst Budd Bugatch saying he views Lowe's shares as more attractive following the third quarter beat. 2. T-Mobile (TMUS) upgraded to Buy from Neutral at MoffettNathanson. 3. GlaxoSmithKline (GSK) upgraded to Buy from Neutral at UBS with analyst Michael Leuchten saying concerns of continuing earnings decline and the dividend sustainability are now overdone. 4. Ciena (CIEN) upgraded to Buy from Neutral at BofA/Merrill with analyst Tal Liani saying shares are at the low end of the historical range and the earnings growth profile is attractive. 5. Constellium (CSTM) upgraded to Outperform from Market Perform at Cowen with analyst Novid Russell saying the company's rapid deleveraging has allowed investors to focus on its significant growth projects, attractive end markets, and valuation discount relative to peers. Russell raised his price target to $13 from $11 on Constellium shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/30/17
ARGS
11/30/17
NO CHANGE
Target $40
ARGS
Buy
GlaxoSmithKline price target lowered to $40 from $50 at Argus
Argus analyst John Eade lowered his price target on GlaxoSmithKline to $40 but kept his Buy rating, saying that the 10% decline in stock price over the past quarter presents a buying opportunity. Eade attributes the decline to the company lagging its peers in moving beyond the patent cliff as well as pricing pressure and generic threats to its respiratory blockbuster Advair/Seretide. However, the analyst says the new CEO should be able to accelerate the efforts to leverage the company's strengths, which include consumer products, vaccines and anti-infectives.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$79.27

0.4 (0.51%)

11:46
05/22/18
05/22
11:46
05/22/18
11:46
Technical Analysis
Technical Take: Energy Select Sector SPDR hits new 52-week high »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$85.71

-3.64 (-4.07%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Recommendations
BioMarin analyst commentary  »

BioMarin 'raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

DO

Diamond Offshore

$20.60

0.71 (3.57%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Options
Diamond Offshore call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$104.25

0.17 (0.16%)

11:41
05/22/18
05/22
11:41
05/22/18
11:41
Conference/Events
Albemarle management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 04

    Jun

  • 05

    Jun

GIS

General Mills

$42.00

0.23 (0.55%)

11:40
05/22/18
05/22
11:40
05/22/18
11:40
Conference/Events
General Mills management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

MYND

MYnd Analytics

$2.66

-0.5 (-15.82%)

11:33
05/22/18
05/22
11:33
05/22/18
11:33
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$620.18

-45.5 (-6.84%)

11:32
05/22/18
05/22
11:32
05/22/18
11:32
Technical Analysis
Technical Take: AutoZone back near lows of the day »

After a brief bounce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TJX

TJX

$87.50

2.84 (3.35%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Earnings
TJX sees Q2 revenue approx. $9B, consensus $8.47B »

Expects wage increases to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RCII

Rent-A-Center

$10.07

-0.14 (-1.37%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Options
Notable ratio spread in Rent A Center »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$86.77

2.11 (2.49%)

11:28
05/22/18
05/22
11:28
05/22/18
11:28
Earnings
TJX sees FY19 revenue $37.7B-$37.9B, consensus $37.87B »

Expects pretax profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TGT

Target

$76.39

-0.47 (-0.61%)

, AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

11:27
05/22/18
05/22
11:27
05/22/18
11:27
Earnings
On The Fly: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$76.39

-0.47 (-0.61%)

AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

WMT

Walmart

$84.33

-0.17 (-0.20%)

SHLD

Sears

$3.35

-0.29 (-7.97%)

JCP

J.C. Penney

$2.41

-0.1 (-3.99%)

KSS

Kohl's

$61.15

-4.32 (-6.60%)

W

Wayfair

$84.92

-0.6 (-0.70%)

TSLA

Tesla

$277.25

-7.24 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 01

    Jun

  • 04

    Jun

  • 19

    Jun

11:25
05/22/18
05/22
11:25
05/22/18
11:25
Conference/Events
RBC commodity strategist to hold a luncheon meeting »

Group Luncheon Meeting,…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary  »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ADSK

Autodesk

$138.56

1.05 (0.76%)

11:20
05/22/18
05/22
11:20
05/22/18
11:20
Options
Autodesk calls active ahead of earnings »

Autodesk calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

TJX

TJX

$86.18

1.52 (1.80%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Hot Stocks
TJX 'disproportionally' attracting millennial customers »

TJX "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/22/18
05/22
11:16
05/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/18
05/22
11:15
05/22/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

TJX

TJX

$86.14

1.48 (1.75%)

11:13
05/22/18
05/22
11:13
05/22/18
11:13
Recommendations
TJX analyst commentary  »

JPMorgan stays Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

CCJ

Cameco

$10.72

-0.66 (-5.80%)

11:10
05/22/18
05/22
11:10
05/22/18
11:10
Options
Call buyers in Cameco as shares see relative weakness »

Call buyers in Cameco as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$41.71

0.38 (0.92%)

11:08
05/22/18
05/22
11:08
05/22/18
11:08
Conference/Events
Suncor management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

SAGE

Sage Therapeutics

$161.81

-1.43 (-0.88%)

11:04
05/22/18
05/22
11:04
05/22/18
11:04
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.